Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor family 8 subfamily B member 4 (OR8B4) is a member of the large family of olfactory receptors, which are G protein-coupled receptors (GPCRs) expressed in the olfactory epithelium and responsible for the initiation of neuronal responses to odorant molecules, ultimately resulting in the perception of smells[1][2][3][8]. Like other olfactory receptors, OR8B4 possesses a canonical structure featuring seven transmembrane domains and mediates signal transduction via activation of G proteins[2][5][8]. Notably, OR8B4 is considered a segregating pseudogene in humans—some individuals harbor a functional gene variant capable of encoding a full-length receptor protein, while in others, the gene contains alterations predicted to abolish function[1]. There is currently no evidence for therapeutic utility, disease association, or targeting by any approved or experimental drugs. Its primary biological role, when functional, is restricted to olfactory signal detection[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 8 subfamily B member 4 (OR8B4).